Drug
Shr8554 And Shr0410
Shr8554 And Shr0410: highest development phase Phase 2, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| SHR8554 Injection and SHR0410 Injection NCT05470049 | Phase 2 | Pain |
Latest
No recent events.
Follow Shr8554 And Shr0410 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.